Skip to main content
FinSpry Logo
FinSpry
CSTL logo
CSTL
(NASDAQ)
Castle Biosciences, Inc.
$21.38-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Castle Biosciences (CSTL) Stock Price & Financial Analysis

Castle Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.05 - $21.93
52-Week High$44.28
52-Week Low$14.59
Open$21.07
Volume439.26K
Average Volume (3M)403.66K
Market Cap639.03M
Shares Outstanding29.89M
Price to Sales (P/S)1.88
Price to Book (P/B)1.38
EV/EBITDA-92.08
Revenue (TTM)339.92M
Net Income (TTM)-22.16M
Free Cash Flow (TTM)4.52M
EPS (TTM)$-0.75
Profit Margin-6.52%
Operating Margin-9.79%
Return on Equity (ROE)-4.80%
Debt to Equity0.08
50-Day MA$21.84
200-Day MA$28.69
52-Week Change13.42%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Castle Biosciences

What is the current stock price for CSTL?

As of the latest trading session, CSTL stock trades at $21.38. The 52-week range is $14.59–$44.28, with a day range of $21.05–$21.93.

What is the P/E ratio for CSTL?

The P/E ratio (Price-to-Earnings) for CSTL is shown in the Key Statistics section. This valuation metric helps compare Castle Biosciences, Inc. to industry peers.

Does CSTL pay dividends?

Castle Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CSTL?

Based on 7 analysts, the consensus for CSTL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CSTL?

Castle Biosciences's market capitalization is $639.0M, classifying it as a small-cap company. Castle Biosciences operates in the Healthcare sector within the Diagnostics & Research industry.